America Wants to Make More Generic Drugs. India Shows Why That’s Hard.

New York Times - Oct 2, 2026

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.

Read full article

More News

The Financial Metrics

The Financial Metrics delivers breaking news and delves into the insights of business with progressive financial advice for today’s advanced business environment.

NEWSLETTER